Literature DB >> 11490827

Treatment of Helicobacter pylori in patients with lymphocytic gastritis.

S Niemelä1, T J Karttunen, T Kerola.   

Abstract

BACKGROUND/AIMS: Lymphocytic gastritis is a subtype of chronic gastritis characterized by a marked increase in the number of intraepithelial lymphocytes in the gastric mucosa. Its etiology is unknown, but a proportion of these patients have Helicobacter pylori infection. The aim was to assess the significance of H. pylori treatment in lymphocytic gastritis patients.
METHODOLOGY: The 10 patients with lymphocytic gastritis and either serologically or histologically diagnosed H. pylori infection were treated with a triple therapy and followed by serology and histology after 6-18 months.
RESULTS: The levels of IgG antibodies for H. pylori decreased below 50% of the pretreatment values in all patients. The maximum numbers of intraepithelial lymphocytes decreased significantly (P = 0.005) from the pretreatment values.
CONCLUSIONS: Treatment of H. pylori infection cures lymphocytic gastritis associated with H. pylori infection. H. pylori appears to be one etiological cause of lymphocytic gastritis.

Entities:  

Mesh:

Year:  2001        PMID: 11490827

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  1 in total

1.  Epithelial cell proliferation and glandular atrophy in lymphocytic gastritis: effect of H pylori treatment.

Authors:  Johanna M Mäkinen; Seppo Niemelä; Tuomo Kerola; Juhani Lehtola; Tuomo J Karttunen
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.